COMPARATIVE EFFICACIES OF TICARCILLIN, TICARCILLIN CLAVULANIC ACID, PIPERACILLIN AND CEFOXITIN AGAINST POLYMICROBIAL INFECTIONS IN MICE CAUSED BY ESCHERICHIA-COLI AND BACTEROIDES-FRAGILIS

被引:2
作者
BEALE, AS
GISBY, J
机构
[1] Smith Kline Beecham Pharmaceuticals, Betchworth, RH3 7AJ, Surrey, Brockham Park
关键词
D O I
10.1007/BF01645577
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A model of localised abscess formation was used to establish mixed infections caused by Escherichia coli and Bacteroides fragilis. The beta-lactamase producing, ticarcillin-resistant strains E. coli E96 and B. fragilis VPI 8708 were used to produce one infection, and in another infection, a beta-lactamase hyperproducing strain E. coli 41548 was combined with a ticarcillin-susceptible strain, B. fragilis B3. Treatment, at doses producing clinically achievable concentrations in mouse serum, began 1 h after inoculation, and continued three times daily for four days. Bacterial numbers in infected tissue were measured at intervals. Against both infections, ticarcillin was ineffective in preventing bacterial growth and abscess formation in all mice. Piperacillin prevented abscess formation in 60% of the mice infected with E. coli E96/B. fragilis VPI 8708, and in 40% of those in the E. coli 41548/B. fragilis B3 group. Therapy with ticarcillin/clavulanic acid or cefoxitin reduced the number of both organisms at the site of infection, and thus prevented abscess formation in 100% treated animals.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 17 条
[1]   EFFICACY OF AMOXYCILLIN CLAVULANIC ACID IN EXPERIMENTAL BACTEROIDES-FRAGILIS ESCHERICHIA-COLI MIXED INFECTIONS [J].
BEALE, AS ;
GISBY, J ;
SUTHERLAND, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (04) :451-459
[2]   BACTERICIDAL EFFECTS OF TICARCILLIN-CLAVULANIC ACID AGAINST BETA-LACTAMASE-PRODUCING BACTERIA INVIVO [J].
BOON, RJ ;
BEALE, AS ;
SUTHERLAND, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) :838-844
[3]   PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL OF TICARCILLIN AND CEPHALOTHIN AS PROPHYLACTIC ANTIBIOTICS FOR GASTROINTESTINAL OPERATIONS [J].
BROWN, JJ ;
MUTTON, TP ;
WASILAUSKAS, BL ;
MYERS, RT ;
MEREDITH, JH .
AMERICAN JOURNAL OF SURGERY, 1982, 143 (03) :343-348
[4]  
BURKE JF, 1961, SURGERY, V50, P161
[5]   INVITRO ACTIVITY OF TICARCILLIN PLUS CLAVULANIC ACID AGAINST 632 CLINICAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
THORNSBERRY, C ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :392-394
[6]  
GISBY J, 1984, ANTIMICROB AGENTS CH, V25, P1830
[7]  
JACKSON D, 1983, 13TH P ICC VIENN, P55
[8]   SINGLE-DOSE SURGICAL PROPHYLAXIS USING TICARCILLIN CLAVULANIC ACID (TIMENTIN) - A PROSPECTIVE, RANDOMIZED COMPARISON WITH CEFOTAXIME [J].
JONES, RN ;
WOJESKI, WV .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 7 (03) :219-223
[9]  
KAISER AB, 1986, NEW ENGL J MED, V315, P1129
[10]  
MANDELL GL, 1985, CLIN THER, V7, P37